HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of opioid blockade with naltrexone and distraction on cold and ischemic pain in hypertension.

Abstract
Essential hypertension is characterised by reduced pain sensitivity. Hypertensive hypoalgesia has been attributed to elevated endogenous opioids and/or increased activation of descending pain modulation systems. A double-blind placebo-controlled design compared the effects of naltrexone and placebo on cold and ischemic pain in unmedicated newly-diagnosed patients with essential hypertension. Patients performed a cold pressor task while resting and while performing a distracting secondary task. They also performed a forearm ischemia task while resting. Although the cold pressor and ischemia tasks elicited significant increases in pain and blood pressure, pain ratings and pressor responses did not differ between naltrexone and placebo. Cold pain was reduced by distraction compared to rest. The finding that opioid blockade with naltrexone did not moderate the pain and pressor responses to cold and ischemia suggests that pain and associated blood pressure responses are not modulated by opioids in hypertension. The finding that the distracting secondary task successfully reduced pain ratings suggests normal supraspinal pain modulation in essential hypertension.
AuthorsChristopher Ring, Christopher R France, Mustafa al'Absi, Louise Beesley, Louisa Edwards, David McIntyre, Douglas Carroll, Una Martin
JournalJournal of behavioral medicine (J Behav Med) Vol. 30 Issue 1 Pg. 59-68 (Feb 2007) ISSN: 0160-7715 [Print] United States
PMID17205392 (Publication Type: Clinical Trial, Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Narcotic Antagonists
  • Naltrexone
  • beta-Endorphin
Topics
  • Adult
  • Attention
  • Cold Temperature
  • Double-Blind Method
  • Female
  • Heart Rate (physiology)
  • Humans
  • Hypertension (epidemiology, metabolism)
  • Male
  • Myocardial Ischemia (epidemiology, metabolism)
  • Naltrexone (administration & dosage, pharmacology)
  • Narcotic Antagonists (administration & dosage, pharmacology)
  • Pain (diagnosis, epidemiology, metabolism)
  • Pain Measurement
  • Touch
  • beta-Endorphin (antagonists & inhibitors, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: